Matrixx Initiatives, Inc. Names William J. Barba Vice President of Finance and Accounting, and Treasurer
SCOTTSDALE, Ariz., May 19 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets Zicam® products, today announced that Matrixx's Board of Directors has named William J. Barba as Vice President of Finance and Accounting, and Treasurer effective May 6, 2010.
Mr. Barba served as the Company's Treasurer and Director of Planning, since July 2007. Bill, 38, joined the Company in February 2004 in a finance and investor relations role. He assumed additional responsibilities as Director of Planning and Administration in 2006. Prior to joining Matrixx, he held a variety of financial management positions with Mesa Air Group, Honeywell Intellectual Properties, Avnet, and MicroAge.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets Zicam brand pharmaceuticals, including Zicam Cold Remedy in multiple oral delivery forms; Zicam Allergy and Congestion Relief products; as well as Zicam Cough and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to www.Zicam.com. To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at www.matrixxinc.com. For additional information, contact William Hemelt, President and Chief Executive Officer, 602-385-8888, or Bill Barba, VP of Finance & Accounting, 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.
SOURCE Matrixx Initiatives, Inc.
More by this Source
Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs
Feb 05, 2013, 09:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.